Hyderabad-based Bharat Biotech, the manufacturer of indigenous Covid-19 vaccine Covaxin, is aiming to produce 70-80 million doses monthly from December, lagging way behind the government’s 400 million production estimate between…
Currently, phase 2/3 clinical trials of the second indigenously developed Corbevax, an RBD protein sub-unit vaccine to be administered in adults aged 18 years to 80 years, is underway and…
Some of India’s private hospitals have cancelled orders for Russia’s Sputnik V vaccine as they struggle to sell COVID-19 shots amid surging supplies of free doses of other vaccines offered…
Worried about waning immunity levels against the coronavirus, doctors and public health experts feel there is a need to give booster shots to healthcare and frontline workers who were the…
